Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 infection in severe Alpha 1-antitrypsin deficiency: Looking for a rationale
Ilaria Ferrarotti, Stefania Ottaviani, Alice Maria Balderacchi, et al.
Respiratory Medicine (2021) Vol. 183, pp. 106440-106440
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions
Edward D. Chan, Paul T. King, Xiyuan Bai, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1804-1804
Open Access | Times Cited: 5
Severe COVID-19 Illness and α1-Antitrypsin Deficiency: COVID-AATD Study
Juan Luis Rodríguez Hermosa, Gianna Vargas Centanaro, María Estela González Castro, et al.
Biomedicines (2023) Vol. 11, Iss. 2, pp. 516-516
Open Access | Times Cited: 12
Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence
Xiyuan Bai, Tony Schountz, Ashley M. Buckle, et al.
Biochemical Society Transactions (2023) Vol. 51, Iss. 3, pp. 1361-1375
Open Access | Times Cited: 12
Alpha-1 antitrypsin deficiency: current therapy and emerging targets
Oisín F. McElvaney, D. Fraughen, Oliver J. McElvaney, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 3, pp. 191-202
Closed Access | Times Cited: 10
Impact of the COVID-19 Pandemic on People Living With Rare Diseases and Their Families: Results of a National Survey
Maurizio Macaluso, Marc E. Rothenberg, Thomas W. Ferkol, et al.
JMIR Public Health and Surveillance (2024) Vol. 10, pp. e48430-e48430
Open Access | Times Cited: 3
Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential
Carmen Mazzuca, Laura Vitiello, Silvia Travaglini, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19
Xiyuan Bai, Ashley M. Buckle, Eszter K. Vladar, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Is SARS-COV-2 associated with alpha-1 antitrypsin deficiency?
Carlota Rodríguez‐García, Emilio Rodríguez‐Ruiz, Alberto Ruano‐Raviña, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 2, pp. 711-717
Open Access | Times Cited: 7
Analysis of the expression of the Serpina1 gene in SARS-CoV-2 infection: study of a new biomarker
M. Pintanel-Raymundo, Sebastian Menao-Guillén, Juan José Perales-Afán, et al.
Revista Clínica Española (English Edition) (2024) Vol. 224, Iss. 5, pp. 253-258
Closed Access | Times Cited: 2
Lower serum alpha 1 antitrypsin levels in patients with severe COVID-19 compared with patients hospitalized due to non-COVID-19 pneumonia
Barak Pertzov, Guy Shapira, Simon Abushkara, et al.
Infectious Diseases (2022) Vol. 54, Iss. 12, pp. 846-851
Closed Access | Times Cited: 8
Improving Detection of Alpha-1 Antitrypsin Deficiency: Role of the Allergist
Timothy Craig, Mark L. Corbett, J. Allen Meadows
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 8, pp. 2348-2354
Open Access | Times Cited: 4
The “Elastic Perspective” of SARS-CoV-2 Infection and the Role of Intrinsic and Extrinsic Factors
Federica Boraldi, Francesco Demetrio Lofaro, Andrea Cossarizza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1559-1559
Open Access | Times Cited: 7
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency: The IMCA1 Study of the EARCO Clinical Research Collaboration
David Parr, Joanna Chorostowska‐Wynimko, Angelo Guido Corsico, et al.
Archivos de Bronconeumología (2022) Vol. 58, Iss. 12, pp. 840-842
Open Access | Times Cited: 7
New coronavirus infection (COVID-19) and respiratory diseases / pathological conditions
Д. И. Трухан
Meditsinskiy sovet = Medical Council (2022) Vol. 16, Iss. 18, pp. 154-161
Open Access | Times Cited: 6
Leave no one behind: inclusion of alpha-1 antitrypsin deficiency patients in COVID-19 vaccine trials
Chengliang Yang, Hedi Zhao, Scott J. Tebbutt
European Journal of Human Genetics (2022) Vol. 30, Iss. 8, pp. 872-874
Open Access | Times Cited: 5
Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients
D. R. Nygren, Ulrica Mölstad, Hans Thulesius, et al.
International Journal of General Medicine (2022) Vol. Volume 15, pp. 5843-5848
Open Access | Times Cited: 5
Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses
Andrea Vianello, Gabriella Guarnieri, Fausto Braccioni, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4493-4493
Open Access | Times Cited: 7
d‐Galactose treatment increasesACE2,TMPRSS2, andFURINand reducesSERPINA1mRNAexpression inA549human lung epithelial cells
Gabriele Baristaite, David Gurwitz
Drug Development Research (2021)
Closed Access | Times Cited: 4
Role of the alpha-1 antitrypsin towards progression and severity of COVID- 19 infection among Saudi patients
Rabab A. Ali, Walaa A. Mohammedsaeed, Hesham A. Fakher, et al.
Research Square (Research Square) (2024)
Open Access
COVID-19 in Individuals with Severe Alpha 1-Antitrypsin Deficiency
Hanan Tanash, Erona Tahiri Blakaj, Eeva Piitulainen, et al.
International Journal of COPD (2024) Vol. Volume 19, pp. 2661-2669
Open Access
Análisis de la expresión del gen SERPINA1 en la infección por SARS-CoV-2: estudio de un nuevo biomarcador
M. Pintanel-Raymundo, Sebastian Menao-Guillén, Juan José Perales-Afán, et al.
Revista Clínica Española (2024) Vol. 224, Iss. 5, pp. 253-258
Closed Access
Hospital Admission Trends in Alpha-1-Antitrypsin Deficiency: A Sex-Based Analysis from the Spanish National Discharge Database, 2016–2022
Javier de Miguel‐Díez, Ana López‐de‐Andrés, José J. Zamorano‐León, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 21, pp. 6564-6564
Open Access
Does hypersialylation compensate the functional Alpha1-AntiTrypsin (A1AT) deficiency in all critically ill patients?
Malika Balduyck, Sarah Afif, Brigitte Onraed, et al.
Biochimie (2024)
Closed Access
Telemedicine for Patients with Chronic Pulmonary Diseases in the COVID-19 Era and Beyond
Monica Goldklang, J. Michael Wells, Jeanine D’Armiento
Annals of the American Thoracic Society (2022) Vol. 19, Iss. 9, pp. 1448-1450
Open Access | Times Cited: 2
Proteolysis and deficiency of α1-proteinase inhibitor in SARS-CoV-2 infection
О. Е. Акбашева, Л. В. Спирина, D. A. Dyakov, et al.
Biomeditsinskaya Khimiya (2022) Vol. 68, Iss. 3, pp. 157-176
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top